Compare RGTI & MIR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | RGTI | MIR |
|---|---|---|
| Founded | 2013 | 2005 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Retail: Computer Software & Peripheral Equipment | Industrial Machinery/Components |
| Sector | Technology | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 7.8B | 6.2B |
| IPO Year | N/A | N/A |
| Metric | RGTI | MIR |
|---|---|---|
| Price | $16.46 | $21.04 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 8 | 8 |
| Target Price | ★ $33.50 | $28.38 |
| AVG Volume (30 Days) | ★ 32.4M | 2.5M |
| Earning Date | 03-04-2026 | 02-10-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ 0.11 |
| Revenue | $7,494,000.00 | ★ $925,400,000.00 |
| Revenue This Year | N/A | $8.93 |
| Revenue Next Year | $179.00 | $22.64 |
| P/E Ratio | ★ N/A | $213.09 |
| Revenue Growth | N/A | ★ 7.50 |
| 52 Week Low | $6.86 | $12.00 |
| 52 Week High | $58.15 | $30.28 |
| Indicator | RGTI | MIR |
|---|---|---|
| Relative Strength Index (RSI) | 34.77 | 29.25 |
| Support Level | $14.84 | $23.02 |
| Resistance Level | $17.97 | $24.74 |
| Average True Range (ATR) | 1.61 | 1.17 |
| MACD | -0.30 | -0.41 |
| Stochastic Oscillator | 14.66 | 6.00 |
Rigetti Computing Inc is engaged in the business of full-stack quantum computing. The company offers full-stack quantum computing platform as a cloud service to a wide range of end-users, directly through its Rigetti QCS platform, and also through cloud service providers. Its proprietary quantum-classical infrastructure provides ultra-low latency integration with public and private clouds for high-performance practical quantum computing. The company has developed the industry's first multi-chip quantum processor for scalable quantum computing systems. Geographically, the company derives the majority of its revenue from the United States.
Mirion Technologies Inc provides products, services, and software that allow customers to safely leverage the power of ionizing radiation for applications that benefit the health, safety, vitality, and technological progress of the human experience. The Company manages its operations through two segments: Nuclear & Safety and Medical. The Medical segment improves the quality and safety of cancer care delivery and supports applications across medical diagnostics and practitioner safety. The Nuclear & Safety segment powers advancements in nuclear energy and critical radiation safety, measurement and analysis applications across laboratories, research and other industrial markets such as defense.